Results of a patient-level pooled analysis of three studies of trastuzumab deruxtecan in HER2-positive breast cancer with active brain metastasis.
Bartsch R, Pérez-García JM, Furtner J, Berghoff AS, Marhold M, Starzer AM, Hughes M, Kabraji S, Sammons S, Anders C, Murthy RK, Van Swearingen AED, Pereslete A, Gion M, Vaz Batista M, Braga S, Pinto PBC, Sampayo-Cordero M, Llombart-Cussac A, Preusser M, Cortés J, Lin NU.
Bartsch R, et al. Among authors: pinto pbc.
ESMO Open. 2025 Jan 3;10(1):104092. doi: 10.1016/j.esmoop.2024.104092. Online ahead of print.
ESMO Open. 2025.
PMID: 39754978